Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD

NCT06192004 · clinicaltrials.gov ↗
TERMINATED
Status
83
Enrollment
INDUSTRY
Sponsor class

Stopped Observed event rate was below the rate required to meet study objectives.

Conditions

Interventions

Sponsor

AstraZeneca